Quick answer
Baker Hughes Company (BKR) reported revenue of $27.73B and net income of $2.59B for the fiscal year ended 2025-12-31, down 0.3% from $27.83B the year before, per its 10-K filed with the SEC on 2026-02-05.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $27.73B | $2.59B | — |
| 2024 (FY ending 2024-12-31) | $27.83B | $2.98B | — |
| 2023 (FY ending 2023-12-31) | $25.51B | $1.94B | — |
| 2022 (FY ending 2022-12-31) | $21.16B | -$601.0M | — |
| 2021 (FY ending 2021-12-31) | $20.50B | -$219.0M | — |
| 2020 (FY ending 2020-12-31) | $20.70B | -$9.94B | — |
| 2019 (FY ending 2019-12-31) | $23.84B | $128.0M | — |
| 2018 (FY ending 2018-12-31) | $22.88B | $195.0M | — |
| 2017 (FY ending 2017-12-31) | $17.18B | -$103.0M | — |
| 2016 (FY ending 2016-12-31) | $13.08B | $0.0M | — |
Frequently asked questions
What is Baker Hughes Company's annual revenue?
Baker Hughes Company (BKR) reported revenue of $27.73B and net income of $2.59B for the fiscal year ended 2025-12-31, down 0.3% from $27.83B the year before, per its 10-K filed with the SEC on 2026-02-05.
What is BKR's profit margin?
Baker Hughes Company's net margin was 9.3% in the fiscal year ended 2025-12-31.
Related
- BIIB revenue, net income and debt history (Biogen Inc.)
- BIO revenue, net income and debt history (Bio-Rad Laboratories, Inc.)
- BJ revenue, net income and debt history (Bj’S Wholesale Club Holdings, Inc.)
- BLK revenue, net income and debt history (BlackRock, Inc.)
- BMNR revenue, net income and debt history (Bitmine Immersion Technologies, Inc.)
- BMRN revenue, net income and debt history (Biomarin Pharmaceutical Inc)
- BMY revenue, net income and debt history (Bristol-Myers Squibb Company)
- BNY revenue, net income and debt history (Bank of New York Mellon Corp)
Last updated Oct 16, 2026, 10:42 PM ET. Data only, not financial or tax advice.